It was also pointed out in a clinical study that serum DDIT4 levels in hyperlipidemia patients were significantly reduced, and the serum DDIT4 content was negatively correlated with blood glucose, blood lipid, insulin resistance, and inflammatory markers, which is consistent with our research conclusion [62]. The gene discussed is DDIT4; the disease is hyperlipidemia.